Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details Narrative)

v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 15, 2022
Apr. 29, 2022
Feb. 16, 2021
Feb. 16, 2021
Feb. 10, 2021
Feb. 28, 2021
Dec. 31, 2022
Dec. 31, 2021
Oct. 10, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock, shares authorized             250,000,000 250,000,000 250,000,000
Common stock, par value             $ 0.001 $ 0.001  
Stockholders' equity, reverse stock split         reverse stock split        
Proceeds from issuance of common stock             $ 24,679,000  
Stock issued during period, value, new issues                
Adjustments to additional paid in capital, fair value             3,032,000 $ 251,000  
Share-Based Payment Arrangement, Noncash Expense             $ 7,700,000    
Preferred stock, par value             $ 0.01 $ 0.01  
Options outstanding intrinsic value             $ 0    
Stock options exercisable price             $ 2.55    
Forfeited             205,000  
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value             $ 3,032,000    
Non- vested number of shares issued             275,101    
Share based compensation unvested intrinsic value             $ 645,172    
Stock option granted             1,532,952 302,500  
Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock exercise warrants               3,074,017  
Warrants cash proceeds               $ 16,400,000  
Series C Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Preferred stock, shares outstanding             96,230 96,230  
Preferred stock, par value             $ 0.01    
Preferred stock, shares issued             96,230 96,230  
Series J One Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Preferred stock, shares outstanding             0 0  
Preferred stock, par value             $ 0.01    
Preferred stock, shares issued             0 0  
Series J Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Debt instrument, convertible, conversion price             $ 3.40    
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent             9.99%    
Common shares issued upon conversion of notes payable, shares           2,353,548      
Series K Preferred Stocks [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Fair value       115,000          
Preferred stock, par value     $ 0.01 $ 0.01          
Convertible shares issuable     100 100          
Series K Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Preferred stock, shares outstanding             0 0  
Preferred stock, shares issued             0 0  
Employment Agreements [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Fair value     4,379,407       312,815 4,040,524  
Stock issued during period, value, new issues     $ 18,600,000            
IPO [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock exercise warrants     5,192,250 5,192,250          
Exercise price per share     $ 5.50 $ 5.50          
Warrant term     5 years 5 years          
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock exercise warrants               3,074,017  
Fair value               692,000  
Stock issued during period, value, new issues               $ 1,000  
Adjustments to additional paid in capital, fair value              
Number of shares issued for service             290,999    
Common shares issued upon conversion of notes payable, shares             338,000    
Common Stock [Member] | Series J Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common shares issued upon conversion of notes payable, shares             692,220    
Common Stock [Member] | Convertible Note [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Debt face amount     $ 33,300,000 $ 33,300,000          
Debt instrument, increase, accrued interest       5,500,000          
Debt conversion converted instrument amount       $ 38,800,000          
Debt instrument, convertible, conversion price     $ 3.40 $ 3.40          
Debt conversion, converted instrument, shares issued       11,413,322          
Common Stock [Member] | IPO [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock, capital shares reserved for future issuance     4,945,000 4,945,000          
Proceeds from issuance of common stock       $ 24,700,000          
Stock issued during period, value, new issues               $ 1,100,000  
Owners [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock, shares authorized                 750,000,000
Investors [Member] | Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock exercise warrants     5,192,250 5,192,250          
Exercise price per share     $ 5.50 $ 5.50          
Class of warrant expire term       5 years          
Note Holder [Member] | Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Fair value               11,086,024  
Remaining number of common shares             327,298 327,298  
Stock issued during period, value, new issues               $ 1,100,000  
Stock repurchase program, remaining authorized repurchase amount                 $ 1,100,000
Additional paid in capital, common stock             $ 10,404    
Adjustments to additional paid in capital, fair value             $ 35,000    
Officers and Directors [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares issued for service           12,500 396,708    
Share-Based Payment Arrangement, Noncash Expense             $ 1,500,000 $ 16,900,000  
Share based compensation cancelled               278,058  
Stock Issued During Period, Value, Issued for Services           $ 38,000 $ 994,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number             44,818    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value             $ 206,035    
Consultants [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Fair value             370,744 2,432,895  
Number of shares issued for service             156,113 649,511  
Share-Based Payment Arrangement, Noncash Expense             $ 1,300,000 $ 9,200,000  
Stock Issued During Period, Value, Issued for Services             $ 791,000 $ 6,100,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number             46,343    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value             $ 162,664    
Shares, Issued     2,850,090 2,850,090          
[custom:CommonStockConsultantToFairValue]       $ 10,700,000          
Chief Executive Officer [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares received   1,845,000              
Legal and professional expenses   $ 224,243              
Consultant Employees Officers And Directors [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Fair value 3,400,000                
Stock option granted 1,532,952                
Stock options exercisable price $ 2.48                
Expected term 6 years 3 months 7 days                
Expected volatility 125.53%                
Risk free interest rate 3.03%                
Dividend yield 0.00%                
Consultant Employees Officers And Directors [Member] | Minimum [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Vesting period 5 months                
Consultant Employees Officers And Directors [Member] | Maximum [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Vesting period 36 months                
Employees [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Forfeited             205,000    
Two Employees [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock option granted               251,000  
Stock options exercisable price               $ 3.05  
Expected term 5 years 6 months                
Expected volatility               129.00%  
Risk free interest rate               1.26%  
Dividend yield               0.00%  
Stock option granted               302,500  
Options expiration period               10 years  
Fair value of options               $ 808,280  
Fair value of stock option, per share               $ 2.67